<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: To determine whether decreased serum insulin-like growth factor-1 (IGF-1) levels could be a risk factor for <z:hpo ids='HP_0000726'>dementia</z:hpo> in older people </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: Case control study </plain></SENT>
<SENT sid="2" pm="."><plain>SETTING: Showa University Karasuyama Hospital, Tokyo, Japan </plain></SENT>
<SENT sid="3" pm="."><plain>PARTICIPANTS: A total of 436 Japanese elderly subjects: 106 patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD), 103 patients with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD), and 227 age-matched controls without <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>MEASUREMENTS: Serum concentrations of IGF-1 and atherogenic <z:chebi fb="2" ids="6495">lipoproteins</z:chebi>, carotid artery intima-media thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>), and plaques were determined </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Mini-Mental State Examination (MMSE) scores were positively correlated with serum IGF-1 concentrations as well as mean blood pressure or body mass index and were negatively correlated with age, serum <z:chebi fb="1" ids="47774">low-density lipoprotein cholesterol</z:chebi> and <z:chebi fb="1" ids="6495">lipoprotein</z:chebi>(a) concentrations, and carotid <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Serum IGF-1 concentrations had a significant inverse correlation with carotid <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Analysis across the IGF-1 quartiles revealed a threshold effect of low IGF-1 on MMSE score in subjects with the IGF-1 levels of 140 ng/mL or less (50% percentile) versus those with IGF-1 levels greater than 140 ng/mL </plain></SENT>
<SENT sid="8" pm="."><plain>Multiple logistic regression concerning AD and VaD retained serum IGF-1 concentrations of 140 ng/mL or less and carotid <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> of 0.9 mm or more </plain></SENT>
<SENT sid="9" pm="."><plain>Patients with AD and VaD had significantly lower IGF-1 concentrations and greater mean <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> than nondemented controls </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: These results suggest that decreased serum IGF-1 level and the progression of carotid <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> could play a role as independent risk factors for <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
</text></document>